Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type.

Détails

Ressource 1Télécharger: 32145660.pdf (1251.56 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_BD684EDE54A6
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type.
Périodique
Drug and alcohol dependence
Auteur(s)
Lefrancois E., Belackova V., Silins E., Latimer J., Jauncey M., Shimmon R., Mozaner Bordin D., Augsburger M., Esseiva P., Roux C., Morelato M.
ISSN
1879-0046 (Electronic)
ISSN-L
0376-8716
Statut éditorial
Publié
Date de publication
01/04/2020
Peer-reviewed
Oui
Volume
209
Pages
107909
Langue
anglais
Notes
Publication types: Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
Providing information about substances injected can reduce the negative impact of illicit drug consumption and support people who inject drugs to make informed decisions. In Australia, information about drugs injected relies largely on periodic self-report surveys. For the first time, the analysis of the residual content of used injecting equipment was conducted in a supervised injecting facility (SIF) located in Sydney, Australia. The aim was to gain a better understanding of the substances injected by clients through: (1) chemical analyses of the content of used syringes; (2) comparison of these results with clients' self-reported drug use; and (3) assessing the usefulness of analysing other injecting equipment to detect substances used. During one week in February 2019, syringes and other injecting equipment were collected at the Sydney SIF. Their residual content was analysed by gas-chromatography/mass-spectrometry. Heroin was the most commonly detected substance (present in 51% of syringes), followed by methamphetamine (22%) and oxycodone (10%). In addition to the main psychoactive substance, cutting agents reported in the literature were also detected in used syringes. The main psychoactive substance identified by laboratory analysis reliably corresponded with users' self-reported drug type. Analytical confirmation of substances injected allows for the provision of better targeted harm reduction messaging based on timely and objective data. The approach used is amenable to clients and feasible in the Australian SIF context. Upscaling and wider implementation could be done through Needle and Syringe Programs, and would support the early detection of harmful substances entering drug markets and better inform harm reduction strategies.
Mots-clé
Adult, Drug Users/psychology, Female, Gas Chromatography-Mass Spectrometry/methods, Humans, Illicit Drugs/adverse effects, Illicit Drugs/analysis, Male, Needle-Exchange Programs/methods, New South Wales/epidemiology, Self Report, Substance Abuse, Intravenous/diagnosis, Substance Abuse, Intravenous/epidemiology, Surveys and Questionnaires, Syringes, Chemical analysis, Harm reduction, Illicit drugs, Needle exchange programs, People who inject drugs (PWID)
Pubmed
Web of science
Open Access
Oui
Création de la notice
26/02/2020 11:15
Dernière modification de la notice
25/02/2021 7:10
Données d'usage